1. Home
  2. HROW vs SEDG Comparison

HROW vs SEDG Comparison

Compare HROW & SEDG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HROW
  • SEDG
  • Stock Information
  • Founded
  • HROW 1998
  • SEDG 2006
  • Country
  • HROW United States
  • SEDG Israel
  • Employees
  • HROW 382
  • SEDG N/A
  • Industry
  • HROW Biotechnology: Pharmaceutical Preparations
  • SEDG Semiconductors
  • Sector
  • HROW Health Care
  • SEDG Technology
  • Exchange
  • HROW Nasdaq
  • SEDG Nasdaq
  • Market Cap
  • HROW 1.4B
  • SEDG 1.5B
  • IPO Year
  • HROW N/A
  • SEDG 2015
  • Fundamental
  • Price
  • HROW $39.22
  • SEDG $33.31
  • Analyst Decision
  • HROW Strong Buy
  • SEDG Sell
  • Analyst Count
  • HROW 7
  • SEDG 22
  • Target Price
  • HROW $64.67
  • SEDG $18.92
  • AVG Volume (30 Days)
  • HROW 671.7K
  • SEDG 4.6M
  • Earning Date
  • HROW 08-11-2025
  • SEDG 08-07-2025
  • Dividend Yield
  • HROW N/A
  • SEDG N/A
  • EPS Growth
  • HROW N/A
  • SEDG N/A
  • EPS
  • HROW N/A
  • SEDG N/A
  • Revenue
  • HROW $227,661,000.00
  • SEDG $940,561,000.00
  • Revenue This Year
  • HROW $46.17
  • SEDG $33.45
  • Revenue Next Year
  • HROW $39.97
  • SEDG $20.86
  • P/E Ratio
  • HROW N/A
  • SEDG N/A
  • Revenue Growth
  • HROW 47.69
  • SEDG N/A
  • 52 Week Low
  • HROW $20.85
  • SEDG $10.24
  • 52 Week High
  • HROW $59.23
  • SEDG $34.36
  • Technical
  • Relative Strength Index (RSI)
  • HROW 62.35
  • SEDG 63.92
  • Support Level
  • HROW $37.09
  • SEDG $29.41
  • Resistance Level
  • HROW $39.67
  • SEDG $34.36
  • Average True Range (ATR)
  • HROW 2.41
  • SEDG 2.59
  • MACD
  • HROW 0.10
  • SEDG 0.40
  • Stochastic Oscillator
  • HROW 87.23
  • SEDG 89.86

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

About SEDG SolarEdge Technologies Inc.

SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers.

Share on Social Networks: